Cardiovascular Therapeutics / 2020 / Article / Tab 1

Research Article

Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis

Table 1

HS patients included in the study and assessed with ECG.

Age (years)SexHeight (cm)Weight (kg)BMISmokeHR (bpm)RR (ms)PQ (ms)QRS (ms)QTc (ms)

41F1.688329.4Yes7876811488324.00
16F1.657226.4No9364214858296.00
31M1.79532.9Yes8174014092344.00
15M1.629335.4No8769014078332.00
48M1.89027.8Yes60100417084410.00
13F1.427939.2No8967213480303.00
28F1.78529.4Yes748169870361.00
16M1.858524.8No59102015288404.00
36M1.667727.9No7085614888370.00
19F1.767223.2No7876812276324.00
32F1.658330.5Yes7975814886322.00
28F1.577630.8Yes6789214484349.00
24F1.713045Yes9364415688297.00
16F1.676021.5No83720172108314.00
22M1.859527.8Yes74806104110359.00
21M701.8520.5No6986612088372.00

25.386.2379.8029.5377.125791.375138.12585.375342

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.